Related Experiment Videos
Steroids in multiple sclerosis
1Department of Neurology, Middlesbrough General Hospital, Cleveland, U.K.
Journal of Clinical Pharmacy and Therapeutics
|August 1, 1994
Summary
Short courses of high-dose steroids, specifically methylprednisolone, are effective for multiple sclerosis relapses. This treatment accelerates recovery and has a proven safety profile for short-term use.
Area of Science:
- Neurology
- Immunology
Background:
- Multiple sclerosis (MS) relapses are frequently treated with steroids.
- Long-term steroid therapy is not recommended for managing MS.
Purpose of the Study:
- To evaluate the efficacy and safety of short-term, high-dose methylprednisolone for multiple sclerosis relapses.
Main Methods:
- Review of current clinical practice for MS relapse management.
- Analysis of data on methylprednisolone treatment protocols.
Main Results:
- High-dose methylprednisolone courses accelerate recovery from MS relapses.
- This short-term steroid regimen demonstrates proven safety.
Conclusions:
- Short-term, high-dose methylprednisolone is the current standard for treating MS relapses.
- Repeated short courses are permissible after an interval, maintaining safety and efficacy.